If our business is the leading member of the cooperation, the design follows our design basics.
The logo of the cooperation partner and the business logo is shown in a defined proportion next to the product/category logo.
In November 2014, Pfizer and our company entered into a global strategic alliance that enables the companies to benefit from each other’s strengths and capabilities and further explore the therapeutic potential of avelumab*, an investigational anti-PD-L1 antibody initially discovered and developed by our company .
The alliance between Pfizer and our company is an alliance of equal partners. Thus, in the design of announcements, presentations, and publications, neither partner should visually dominate.
RGB: 0 / 147 / 207
CMYK: 100 / 10 / 0 / 10
PMS: Process Blue
In the case of similar scenarios, please get in touch with firstname.lastname@example.org for further guidance.
* Avelumab is the proposed nonproprietary name for the anti-PD-L1 monoclonal antibody (MSB0010718C).
Our logos are the heart of our brand. They should always be displayed as prominently as possible.Learn more
Science is colorful and we are committed to a colorful future. This is also reflected in our brand.Learn more
Communication is key. We speak with one voice and tell our stories across all channels.Learn more